Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:394593rdf:typepubmed:Citationlld:pubmed
pubmed-article:394593lifeskim:mentionsumls-concept:C0029087lld:lifeskim
pubmed-article:394593lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:394593lifeskim:mentionsumls-concept:C0022885lld:lifeskim
pubmed-article:394593lifeskim:mentionsumls-concept:C1553631lld:lifeskim
pubmed-article:394593pubmed:dateCreated1980-4-23lld:pubmed
pubmed-article:394593pubmed:abstractTextRapidly proliferating tissue incorporates more phosphorus than normal. Thus, following administration of radioactive phosphorus (32P), tumors emit increased amounts of radiation which can be detected. With the proper test technique, a correct diagnosis rate of 96-100% is quoted in the literature. By comparison, between 4 and 20% of all eyes enucleated for suspected malignant melanoma without prior 32P testing contained no neoplasm histologically. The radiation exposure is minimal due to the short half-life of 32P and the low penetration of beta-particles. However, the test usually involves a small operation (conjunctiva and Tenon incision). Testing with gamma rays, however, is not yet wholly satisfactory due to the lack of a suitable gamma-ray detector.lld:pubmed
pubmed-article:394593pubmed:languagegerlld:pubmed
pubmed-article:394593pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:394593pubmed:citationSubsetIMlld:pubmed
pubmed-article:394593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:394593pubmed:statusMEDLINElld:pubmed
pubmed-article:394593pubmed:issn0065-3004lld:pubmed
pubmed-article:394593pubmed:authorpubmed-author:GysinPPlld:pubmed
pubmed-article:394593pubmed:issnTypePrintlld:pubmed
pubmed-article:394593pubmed:volume39lld:pubmed
pubmed-article:394593pubmed:ownerNLMlld:pubmed
pubmed-article:394593pubmed:authorsCompleteYlld:pubmed
pubmed-article:394593pubmed:pagination210-32lld:pubmed
pubmed-article:394593pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-H...lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-E...lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-M...lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-E...lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-P...lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-F...lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-D...lld:pubmed
pubmed-article:394593pubmed:meshHeadingpubmed-meshheading:394593-F...lld:pubmed
pubmed-article:394593pubmed:year1979lld:pubmed
pubmed-article:394593pubmed:articleTitle[The 32P test in ophthalmology].lld:pubmed
pubmed-article:394593pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:394593pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:394593pubmed:publicationTypeReviewlld:pubmed